Related references
Note: Only part of the references are listed.Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway
Hsiu-Chung Ou et al.
ENVIRONMENTAL TOXICOLOGY (2019)
Galectin-3 Levels and Outcomes After Myocardial Infarction A Population-Based Study
Rabea Asleh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Negative Risk Markers for Cardiovascular Events in the Elderly
Martin Bodtker Mortensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
MYOCARDIAL STRAIN PROPERTIES IN PATIENTS WITH CHRONIC HEART FAILURE
A. G. Obrezan et al.
KARDIOLOGIYA (2019)
Inhibition of Galectin-3 Alleviates Cigarette Smoke Extract-Induced Autophagy and Dysfunction in Endothelial Progenitor Cells
ChongZhe Pei et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Association of galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis
Panagiota Anyfanti et al.
CLINICAL CARDIOLOGY (2019)
Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin 1-RhoA-JNK signaling activation
Xiumei Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways
ChongZhe Pei et al.
PHYTOTHERAPY RESEARCH (2019)
NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure
Milos Parovic et al.
ESC HEART FAILURE (2019)
Galectin-3 Enhances Avian H5N1 Influenza A Virus-Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation
Yu-Jung Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors
Hao Zhang et al.
BIOCONJUGATE CHEMISTRY (2018)
Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity
Gema Marin-Royo et al.
DISEASE MODELS & MECHANISMS (2018)
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar et al.
THERANOSTICS (2018)
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
Leo F. Buckley et al.
ESC HEART FAILURE (2018)
Galectin-3-null mice display defective neutrophil clearance during acute inflammation
Rachael D. Wright et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation
Isabel Fort-Gallifa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Overexpression of microRNA-138 alleviates human coronary artery endothelial cell injury and inflammatory response by inhibiting the PI3K/Akt/eNOS pathway
Jing-Bo Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Galectin-3 is associated with coronary plaque burden and obstructive sleep apnoea syndrome severity
Hamdi Pusuroglu et al.
KARDIOLOGIA POLSKA (2017)
Vitexin alleviates ox-LDL-mediated endothelial injury by inducing autophagy via AMPK signaling activation
Shaoli Zhang et al.
MOLECULAR IMMUNOLOGY (2017)
Galectin-3 induces the phenotype transformation of human vascular smooth muscle cells via the canonical Wnt signaling
Lei Tian et al.
MOLECULAR MEDICINE REPORTS (2017)
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice
Yonggang Lu et al.
MOLECULAR MEDICINE REPORTS (2017)
NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice
Heike Langbein et al.
EUROPEAN HEART JOURNAL (2016)
Inflammation in atherosclerosis
Soraya Taleb
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study
Anna Lisowska et al.
ATHEROSCLEROSIS (2016)
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice
Giuseppe Vergaro et al.
HYPERTENSION (2016)
Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?
Gokhan Aksan et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Extracellular galectin-3 counteracts adhesion and exhibits chemoattraction in Helicobacter pylori-infected gastric cancer cells
Vinod Vijay Subhash et al.
MICROBIOLOGY-SGM (2016)
New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling
Monika Bambouskova et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index
Ana I. Casanegra et al.
VASCULAR MEDICINE (2016)
Doxazosin Stimulates Galectin-3 Expression and Collagen Synthesis in HL-1 Cardiomyocytes Independent of Protein Kinase C Pathway
Xiaoqian Qian et al.
FRONTIERS IN PHARMACOLOGY (2016)
Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
Tung-Ju Hsieh et al.
SCIENTIFIC REPORTS (2016)
Prognostic biomarkers in acute coronary syndrome
Gian Luca Salvagno et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Galectin-3 Predicts Long-Term Cardiovascular Death in High-Risk Patients With Coronary Artery Disease
Giuseppe Maiolino et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes
April L. Darrow et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference
Swey-Shen Chen et al.
CELLULAR IMMUNOLOGY (2015)
Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus
Derya Ozturk et al.
CORONARY ARTERY DISEASE (2015)
Recent insights into the cellular biology of atherosclerosis
Ira Tabas et al.
JOURNAL OF CELL BIOLOGY (2015)
Galectin-3-induced oxidized low-density lipoprotein promotes the phenotypic transformation of vascular smooth muscle cells
Lei Tian et al.
MOLECULAR MEDICINE REPORTS (2015)
Atherosclerosis - A matter of unresolved inflammation
Joana Viola et al.
SEMINARS IN IMMUNOLOGY (2015)
Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction
Antonio Lax et al.
JACC-HEART FAILURE (2015)
Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
Varsha Srivatsan et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management
Nasrien Ibrahim et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2015)
Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease
Javier Higueras et al.
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS (2015)
Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice
Anna M. D. Watson et al.
ATHEROSCLEROSIS (2014)
Comprehensive Review of the Prognostic Value of Galectin-3 in Heart Failure
Elliot Coburn et al.
CARDIOLOGY IN REVIEW (2014)
The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure
Wouter C. Meijers et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Aldosterone Induced Galectin-3 Secretion In Vitro and In Vivo: From Cells to Humans
Yen-Hung Lin et al.
PLOS ONE (2014)
Galectin-3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis
Julio Madrigal-Matute et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
Qiu-Sheng Yin et al.
JOURNAL OF GERIATRIC CARDIOLOGY (2014)
The association between galectin-3 and occurrence of reinfarction early after first myocardial infarction treated invasively
Iwona Szadkowska et al.
BIOMARKERS (2013)
The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis
Stefano Menini et al.
CARDIOVASCULAR RESEARCH (2013)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
Nada N. Pejnovic et al.
DIABETES (2013)
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
Alison C. MacKinnon et al.
GLYCOBIOLOGY (2013)
Galectin-3: its role in asthma and potential as an anti-inflammatory target
Peng Gao et al.
RESPIRATORY RESEARCH (2013)
Spatial and Temporal Expression, and Statin Responsiveness of Galectin-1 and Galectin-3 in Murine Atherosclerosis
Yong-Jin Lee et al.
KOREAN CIRCULATION JOURNAL (2013)
Galectin-3 and the Development of Heart Failure after Acute Coronary Syndrome: Pilot Experience from PROVE IT-TIMI 22
E. Wilson Grandin et al.
CLINICAL CHEMISTRY (2012)
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Lars Gullestad et al.
EUROPEAN HEART JOURNAL (2012)
Value and Level of Galectin-3 in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
Tzu-Hsien Tsai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2012)
The fibrosis marker galectin-3 and outcome in the general population
R. A. de Boer et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community
Carolyn S. P. Lam et al.
CIRCULATION (2011)
Matrilysin-1 (MMP7) Cleaves Galectin-3 and Inhibits Wound Healing in Intestinal Epithelial Cells
Manjula Puthenedam et al.
INFLAMMATORY BOWEL DISEASES (2011)
GALECTIN-3 PLASMA LEVELS AND CORONARY ARTERY DISEASE: A NEW POSSIBLE BIOMARKER OF ACUTE CORONARY SYNDROME
C. Falcone et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure
Garvan C. Kane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension
Anne-Catherine Pouleur et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice Role of Lipoxidation via Receptor-Mediated Mechanisms
Carla Iacobini et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Galectin 3 Induces a Distinctive Pattern of Cytokine and Chemokine Production in Rheumatoid Synovial Fibroblasts via Selective Signaling Pathways
Andrew Filer et al.
ARTHRITIS AND RHEUMATISM (2009)
Galectin-3: a novel mediator of heart failure development and progression
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils
Anna Karlsson et al.
GLYCOBIOLOGY (2009)
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation
Gabriel A. Rabinovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice
Maurice Nachtigal et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction
Marianna Papaspyridonos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition
Yoshihiro Suzuki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Regulation of alternative macrophage activation by galectin-3
Alison C. MacKinnon et al.
JOURNAL OF IMMUNOLOGY (2008)
Large artery intracranial occlusive disease - A large worldwide burden but a relatively neglected frontier
Philip B. Gorelick et al.
STROKE (2008)
A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury
Ana Paula Fernandes Bertocchi et al.
TRANSPLANT INTERNATIONAL (2008)
Galectin-3:: An open-ended story
J Dumic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
CD98hc (SLC3A2) interaction with β1 Integrins is required for transformation
NC Henderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of endothelial dysfunction in atherosclerosis
J Davignon et al.
CIRCULATION (2004)
Galectin-3 mediates IL-4-induced survival and differentiation of B cells: Functional cross-talk and implications during Trypanosoma cruzi infection
EV Acosta-Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2004)
Critical role of galectin-3 in phagocytosis by macrophages
H Sano et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins
K Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Mechanisms involved in the stimulatory effect of advanced glycation end products on growth of rat aortic smooth muscle cells
N Seki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Galectinomics: finding themes in complexity
DNW Cooper
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Intracellular functions of galectins
FT Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia
S Sato et al.
JOURNAL OF IMMUNOLOGY (2002)
The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins
WQ Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe
J Almkvist et al.
INFECTION AND IMMUNITY (2001)
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses
DK Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
